SCHEMBL25575744

SCHEMBL25575744

Cc1ccc(OC(F)(F)F)c(N2CCC(=O)NC2=O)c1

nearest known ligand 0.48

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 17/20 0.48
DDB1 Q16531 16/20 0.48
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25920672 0.85 CRBN (0.43) CRBNDDB1ALDH1A1
SCHEMBL25905734 0.84 CRBN (0.42) CRBNDDB1
SCHEMBL23065973 0.84 DDB1 (0.52) CRBNDDB1KDM4EMEN1ALDH1A1
SCHEMBL30430816 0.81 DDB1 (0.40) CRBNDDB1KDM4EALDH1A1HTT
SCHEMBL25216832 0.81 DDB1 (0.40) CRBNDDB1KDM4EALDH1A1HTT
SCHEMBL25905651 0.81 CRBN (0.56) CRBNDDB1
SCHEMBL25575759 0.81 CRBN (0.49) CRBNDDB1KDM4EMEN1ALDH1A1
SCHEMBL25575745 0.80 CRBN (0.51) CRBNDDB1KDM4EMEN1ALDH1A1
SCHEMBL25074350 0.78 CRBN (0.55) CRBNDDB1KDM4EMEN1ALDH1A1
SCHEMBL30014315 0.78 DDB1 (0.37) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4393922-A1 IRAK4 DEGRADATION AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-07-03 EP disclosed
EP-4328219-A1 SOS1 DEGRADING AGENT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Leadingtac Pharmaceutical Co. Ltd. (CN) 2024-02-28 EP disclosed
EP-4194457-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co., Ltd. (CN) 2023-06-14 EP disclosed